Technical Analysis for MCUJF - Medicure Inc

Grade Last Price % Change Price Change
grade F 3.0711 -0.07% -0.0022
MCUJF closed down 0.07 percent on Friday, October 18, 2019, on 14 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical MCUJF trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Gapped Down Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction -0.07%
Gapped Up Strength -0.07%
Oversold Stochastic Weakness -0.07%
MACD Bearish Signal Line Cross Bearish 1.36%
New 52 Week Closing Low Bearish 1.36%
Narrow Range Bar Range Contraction 1.36%
New 52 Week Low Weakness 1.36%

Older signals for MCUJF ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Medicure Inc. (Medicure) is a pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics. The Company operates in the biopharmaceutical industry segment. The Company's primary operating focus is on the sale and marketing of its acute care cardiovascular drug, AGGRASTAT (tirofiban hydrochloride) owned by its subsidiary, Medicure International, Inc. and distributed in the United States and its territories through the Company's United States subsidiary, Medicure Pharma, Inc. AGGRASTAT, a glycoprotein IIb/IIIa inhibitor (GPI), is used for the treatment of acute coronary syndrome (ACS). The Company is also engaged in the development of TARDOXAL for neurological disorders, such as Tardive Dyskinesia (TD). The Company has completed Phase IIa stage of development for TARDOXAL. The Company is also developing Transdermal AGGRASTAT, a cure for acute cardiology. Transdermal AGGRASTAT is in preclinical-stage of development.
Chemistry Medicine Health Pharmaceutical Neurological Disorders Acute Coronary Syndrome Piperidines Tardive Dyskinesia Tirofiban
Is MCUJF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicator Value
52 Week High 6.7102
52 Week Low 3.03
Average Volume 1,466
200-Day Moving Average 4.633
50-Day Moving Average 3.5495
20-Day Moving Average 3.297
10-Day Moving Average 3.2157
Average True Range 0.1049
ADX 18.77
+DI 36.591
-DI 54.2016
Chandelier Exit (Long, 3 ATRs ) 3.2453
Chandelier Exit (Short, 3 ATRs ) 3.3447
Upper Bollinger Band 3.5767
Lower Bollinger Band 3.0173
Percent B (%b) 0.1
BandWidth 16.96694
MACD Line -0.1281
MACD Signal Line -0.1202
MACD Histogram -0.0079
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.0711
Resistance 3 (R3) 3.0711 3.0711 3.0711
Resistance 2 (R2) 3.0711 3.0711 3.0711 3.0711
Resistance 1 (R1) 3.0711 3.0711 3.0711 3.0711 3.0711
Pivot Point 3.0711 3.0711 3.0711 3.0711 3.0711
Support 1 (S1) 3.0711 3.0711 3.0711 3.0711 3.0711
Support 2 (S2) 3.0711 3.0711 3.0711 3.0711
Support 3 (S3) 3.0711 3.0711 3.0711
Support 4 (S4) 3.0711